Press Release: DRI Healthcare Trust Announces Voting Results of AGM

Dow Jones
14 May

DRI Healthcare Trust Announces Voting Results of AGM

Canada NewsWire

TORONTO, May 13, 2025

TORONTO, May 13, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 13, 2025. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March 31, 2025 were elected to serve as trustees for the ensuing year, and Deloitte LLP was reappointed as auditors of the Trust.

Election of Trustees

Voting results for the election of each trustee were as follows:

 
Trustee                 Votes "for" as a           Votes "withheld" as a 
                        percentage                 percentage of votes cast 
                        of votes cast for or       for 
                        withheld                   or withheld for the 
                        for the trustee            trustee 
Gary Collins                              88.19 %                    11.81 % 
Ali Hedayat                               90.22 %                     9.78 % 
Kevin Layden                              90.13 %                     9.87 % 
Athana Mentzelopoulos                     99.75 %                     0.25 % 
Paul Mussenden                            88.65 %                    11.35 % 
Poonam Puri                               89.58 %                    10.42 % 
Tamara Vrooman                            88.26 %                    11.74 % 
 
 

Appointment of Auditors

Unitholders also voted in favour of reappointing Deloitte LLP as auditors of the Trust and authorizing the board of trustees to fix their remuneration (95.75% in favour).

About DRI Healthcare Trust

The Trust is managed by DRI Capital Inc., a pioneer in global pharmaceutical royalty monetization. Since its initial public offering in 2021, the Trust has deployed more than $1.0 billion, acquiring more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. The Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in U.S. dollars under the symbol "DHT.U". To learn more, visit drihealthcare.com or follow us on LinkedIn.

SOURCE DRI Healthcare Trust

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/13/c5642.html

/CONTACT:

For further information, please contact: David Levine, Director, Investor Relations, Tel: (416) 324-5738, ir@drihealthcare.com

Copyright CNW Group 2025 
 

(END) Dow Jones Newswires

May 13, 2025 14:14 ET (18:14 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10